Westfield Capital Management Co. LP Sells 3,120,691 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Westfield Capital Management Co. LP reduced its stake in Option Care Health by 43.0%, now holding approximately 4.14 million shares valued at $144.85 million as of its latest SEC filing.
• Other institutional investors are also adjusting their positions, with JPMorgan Chase increasing its stake by 29.6% and Bessemer Group Inc. growing its stake by 62.3% in the same period.
• Analysts remain optimistic about Option Care Health, with several firms issuing "outperform" ratings and raising price targets, reflecting a general consensus of a “Moderate Buy” rating for the stock.

Westfield Capital Management Co. LP lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 43.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,144,537 shares of the company's stock after selling 3,120,691 shares during the period. Westfield Capital Management Co. LP owned about 2.53% of Option Care Health worth $144,852,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its holdings in Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after acquiring an additional 591,042 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after acquiring an additional 278,158 shares during the last quarter. JPMorgan Chase & Co. increased its position in Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after acquiring an additional 344,875 shares during the period. Allspring Global Investments Holdings LLC lifted its position in Option Care Health by 6,525,926.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock worth $52,459,000 after purchasing an additional 1,500,963 shares during the period. Finally, Comerica Bank increased its holdings in Option Care Health by 13.1% in the 4th quarter. Comerica Bank now owns 1,357,628 shares of the company's stock worth $31,497,000 after purchasing an additional 157,198 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Performance

Shares of Option Care Health stock traded down $0.21 on Thursday, reaching $27.70. 629,777 shares of the company traded hands, compared to its average volume of 1,852,969. The company has a 50 day moving average of $30.82 and a 200 day moving average of $31.94. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The firm has a market capitalization of $4.50 billion, a PE ratio of 22.07, a PEG ratio of 1.78 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The business's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.30 EPS. Equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analyst Upgrades and Downgrades

OPCH has been the topic of several research reports. Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities lifted their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.